FDA Inspection
Therapak CorporationTherapak Corporation – FDA Inspection, Feb 12, 2026
Record Details
This FDA Inspection record concerns Therapak Corporation, with an inspection on February 12, 2026, issued by the Los Angeles District Office, covering medical devices & rad health.
- Person
View Company Profile
ID · 3552cdb8-8d0f-4317-82d6-d64cb29b703a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1304602
- FDA center
- Medical Devices & Rad Health
- Project area
- Product Evaluation: Medical Devices
- Outcome
- Form 483 issued
FDA Citations
2- ISO 13485:2016 Clause 8.2.1Feedback process procedures not documented
- ISO 13485:2016 Clause 8.4Analysis of data not used as input for QMS improvement where necessary
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Therapak Corporation
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2020 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| December 5, 2017 | Not classified | Los Angeles District Office | |
| April 24, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| June 29, 2010 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Therapak Corporation
- FDA Inspection 1119689 - 2020-02-05
- FDA Inspection 1055427 - 2017-12-05
- FDA Inspection 925747 - 2015-04-24
- FDA Inspection 675392 - 2010-06-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.